Reduced catalytic activity of PKM2 thus diverts glucose metabolism flux towards the pentose phosphate pathway to generate adequate reducing power against reactive oxygen species (ROS), thus facilitating tumor cell proliferation. The gene discussed is PKM; the disease is neoplasm.